Authors:
Anand, SS
Yusuf, S
Jacobs, R
Davis, AD
Yi, QL
Gerstein, H
Montague, PA
Lonn, E
Citation: Ss. Anand et al., Risk factors, atherosclerosis, and cardiovascular disease among Aboriginalpeople in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP), LANCET, 358(9288), 2001, pp. 1147-1153
Authors:
Gerstein, HC
Mann, JFE
Yi, QL
Zinman, B
Dinneen, SF
Hoogwerf, B
Halle, JP
Young, J
Rashkow, A
Joyce, C
Nawaz, S
Yusuf, S
Citation: Hc. Gerstein et al., Albuminuria and risk of cardiovascular events, death, and heart failure indiabetic and nondiabetic individuals, J AM MED A, 286(4), 2001, pp. 421-426
Authors:
Dagenais, GR
Yusuf, S
Bourassa, MG
Yi, QL
Bosch, J
Lonn, EM
Kouz, S
Grover, J
Citation: Gr. Dagenais et al., Effects of ramipril on coronary events in high-risk persons - Results of the Heart Outcomes Prevention Evaluation study, CIRCULATION, 104(5), 2001, pp. 522-526
Authors:
Mathew, J
Sleight, P
Lonn, E
Johnstone, D
Pogue, J
Yi, QL
Bosch, J
Sussex, B
Probstfield, J
Yusuf, S
Citation: J. Mathew et al., Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril, CIRCULATION, 104(14), 2001, pp. 1615-1621
Authors:
Lonn, EM
Yusuf, S
Dzavik, V
Doris, CI
Yi, QL
Smith, S
Moore-Cox, A
Bosch, J
Riley, WA
Teo, KK
Citation: Em. Lonn et al., Effects of ramipril and vitamin E on atherosclerosis - The study to evaluate carotid ultrasound changes in patients treated with ramipril and vitaminE (SECURE), CIRCULATION, 103(7), 2001, pp. 919-925